ICON plc

ICON plc is a global healthcare intelligence and clinical research organisation (CRO) that provides a comprehensive range of outsourced services to pharmaceutical, biotechnology, medical device, and government and public health organisations. Their mission is to accelerate the development of drugs and devices that save lives and improve quality of life. ICON employs over 41,000 people across 95 locations in 45 countries, making it one of the largest and most comprehensive CROs in the world. Their services span the entire lifecycle of product development, from early clinical trials through to commercialisation, and can be tailored to meet the specific needs of their clients.

ICON is powered by Healthcare Intelligence, which encompasses their experience, expertise, insights, data, and technology. This allows them to offer innovative and efficient solutions across every phase of clinical research and drug development. They are committed to providing a better tomorrow for their clients, partners, and patients by evolving their best practices to meet the challenges of the ever-changing clinical development landscape. This includes embracing new technologies and implementing patient-centric approaches to ensure that clinical trials are more efficient, inclusive, and impactful.

ICON offers a variety of flexible work arrangements to suit individual needs and preferences. These include the ability to work remotely, flexible work schedules, and the option to work from home, all aimed at providing a work-life balance.

ICON offers a comprehensive benefits package designed to promote employee well-being and work-life balance. The company provides competitive benefits tailored to each country's specific requirements, encompassing healthcare coverage, retirement plans, life insurance, disability insurance, and paid time off. ICON also prioritizes employee development and provides opportunities for personalized learning through a mix of in-person and online programs.

ICON plc is a global healthcare intelligence and clinical research organization dedicated to accelerating the development of drugs and devices that save lives and improve quality of life. Through their comprehensive suite of services, ICON partners with pharmaceutical, biotechnology, medical device, and government and public health organizations to bring life-changing therapies to market, driving innovation and advancing clinical research to positively impact patients worldwide.

ICON promotes a culture of inclusivity and collaboration, valuing diverse perspectives and fostering a vibrant environment where people can grow and contribute to a shared mission. They emphasize the importance of teamwork, innovation, and a commitment to exceeding quality standards, all while upholding a strong ethical foundation and prioritizing the well-being of employees and patients.

ICON plc recognizes the importance of diversity, equity, and inclusion in clinical trials and strives to create an inclusive workplace culture. They are committed to ensuring that clinical trials include representative patient cohorts, particularly focusing on underrepresented groups, to improve the generalizability of results, understand differential responses, and ensure the safety and efficacy of treatments for all. To achieve this, ICON leverages artificial intelligence and human expertise to enhance site selection, identifying diverse connections and ensuring access to clinical trials for marginalized communities.